Antiretroviral treatment outcomes among late HIV presenters initiating treatment with integrase inhibitors or protease inhibitorsGundolf Schuettfort, AE Haberl, Miguel Górgolas et al.|HIV Medicine|2020Cited by 15
Reasons for Choice of Antiretroviral Regimens in HIV Patients Presenting Late for Initial Treatment in EuropeGundolf Schuettfort, Annette E. Haberl, Alfonso Cabello et al.|AIDS Patient Care and STDs|2021Cited by 11
Antiretroviral treatment in people living with HIV with late diagnosis initiating ART with DTG/3TC or BIC/TAF/FTC: A real‐world cohort analysisGundolf Schuettfort, Annette E. Haberl, Jan Borch et al.|HIV Medicine|2025Cited by 1